2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1548473523 D.D.S.
Verify on CMS →

EASWAR NATARAJAN, D.D.S.

Oral and Maxillofacial Pathology Dentistry in FARMINGTON, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
151
Medicare Part D claims · 43 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
What the federal data reveals: EASWAR NATARAJAN, D.D.S. is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in FARMINGTON, Connecticut with a Medicare Part D prescribing footprint of 151 claims across 43 beneficiaries .

What stands out: EASWAR NATARAJAN, D.D.S. filed 151 Medicare Part D claims in 2023 across FARMINGTON, Connecticut. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

EASWAR NATARAJAN, D.D.S. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/07/2007

NPI 1548473523

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

151 50% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in Connecticut

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among Connecticut providers

Connecticut providers

Oral and Maxillofacial Pathology Dentistry share within Connecticut

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

EASWAR NATARAJAN, D.D.S. is a Oral and Maxillofacial Pathology Dentistry provider practicing in FARMINGTON, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.D.S.. NPI: 1548473523. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

EASWAR NATARAJAN, D.D.S. appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding D.D.S. credentials at 263 FARMINGTON AVENUE, FARMINGTON, CT, 06030, with a listed phone of (860) 679-3170. NPI 1548473523 was issued on 05/07/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NATARAJAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 151 prescription claims written by this provider, covering 43 Medicare beneficiaries and totaling roughly $8K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

263 FARMINGTON AVENUE
FARMINGTON, CT 06030

Provider Details

NPI 1548473523
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials D.D.S.
Gender Male
NPI Issued 05/07/2007

Hospital and facility affiliations

Facilities where EASWAR NATARAJAN, D.D.S. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY DENTISTS
FARMINGTON, CT
UNIVERSITY OF CONNECTICUT HEALTH CENTER
FARMINGTON, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

151
Total Claims
$8K
Total Drug Cost
43
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
232
Total Day Supply
6,500
Brand Drug Cost
$0
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
1.11
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Dexamethasone
110
Doxycycline Hyclate
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How EASWAR NATARAJAN, D.D.S. fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

EASWAR NATARAJAN, D.D.S.'s 151 claims are below the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as NATARAJAN.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is EASWAR NATARAJAN, D.D.S.'s specialty?
EASWAR NATARAJAN, D.D.S. specializes in Oral and Maxillofacial Pathology Dentistry and practices in FARMINGTON, Connecticut. Credentials: D.D.S..
How much does EASWAR NATARAJAN, D.D.S. prescribe under Medicare Part D?
In 2023, EASWAR NATARAJAN, D.D.S. wrote 151 Medicare Part D claims totaling $8K in drug costs for 43 beneficiaries.
Where is EASWAR NATARAJAN, D.D.S. located?
EASWAR NATARAJAN, D.D.S. is located at 263 FARMINGTON AVENUE, FARMINGTON, CT, 06030. Phone: (860) 679-3170.
What is EASWAR NATARAJAN, D.D.S.'s NPI number?
EASWAR NATARAJAN, D.D.S.'s National Provider Identifier (NPI) is 1548473523, issued on 05/07/2007.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does EASWAR NATARAJAN, D.D.S. prescribe most often?
Based on 2023 Medicare Part D data, EASWAR NATARAJAN, D.D.S.'s most frequently prescribed drugs include Dexamethasone, Doxycycline Hyclate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does EASWAR NATARAJAN, D.D.S. accept Medicare?
EASWAR NATARAJAN, D.D.S. appears in CMS Medicare data with 151 Part D claims and 43 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify EASWAR NATARAJAN, D.D.S.'s credentials?
EASWAR NATARAJAN, D.D.S.'s NPI is 1548473523 with credentials D.D.S.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology